Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent

Benoit Bilanges1, Rhoda Argonza-Barrett, Marina Kolesnichenko

  • 1Cancer Research Institute, University of California, San Francisco, California, USA.

Insights

The tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 regulate protein translation via mTORC1 signaling. Loss of TSC1/TSC2 impairs mRNA translation control, impacting specific mRNAs crucial for tuberous sclerosis pathology.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 are known regulators of the mTORC1 pathway.
  • The precise mechanisms by which TSC1/TSC2 control global protein synthesis and specific mRNA translation under varying stimuli remain unclear.

Purpose of the Study:

  • To investigate how TSC1 and TSC2 regulate protein translation in response to serum withdrawal.
  • To identify specific mRNAs translationally controlled by TSC1/TSC2 and the mTORC1 pathway.

Main Methods:

  • Utilized wild-type and Tsc1/Tsc2-deficient mouse embryo fibroblasts (MEFs).
  • Analyzed mTORC1 signaling, translation initiation complex assembly, and mRNA distribution between polysomes and subpolysomes.
  • Performed microarray analysis on polysome- and subpolysome-associated mRNAs.
  • Investigated the effect of the mTORC1 inhibitor rapamycin.

Main Results:

  • Serum withdrawal inhibited mTORC1 signaling and altered translation complexes in wild-type MEFs, but not in Tsc1/Tsc2-deficient MEFs.
  • 90% of serum-regulated mRNAs were dependent on TSC1 and TSC2 for their translational control.
  • Rapamycin affected only 40% of serum-regulated mRNAs, indicating TSC1/TSC2-dependent regulation beyond mTORC1 inhibition.
  • Re-expression of TSC1/TSC2 restored serum-dependent signaling and mRNA redistribution.
  • Rapamycin-sensitive, serum-responsive mRNAs were enriched for specific untranslated regions (UTRs).

Conclusions:

  • The TSC1/TSC2 complex is a major regulator of protein translation, primarily through mTORC1-dependent mechanisms.
  • Specific mRNA translation profiles are deregulated in TSC, implicating altered translation in the pathology.
  • TSC1/TSC2 control mRNA translation in response to mitogenic and nutritional cues, with implications for tuberous sclerosis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...